X4 Pharmaceuticals Inc
NASDAQ:XFOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gaona Aero Material Co Ltd
SZSE:300034
|
CN |
|
A
|
Amtd International Inc
NYSE:AMTD
|
HK |
|
Bisichi PLC
LSE:BISI
|
UK |
|
Z
|
Zhejiang Renzhi Co Ltd
SZSE:002629
|
CN |
During the last 3 months X4 Pharmaceuticals Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 12% over this period (open performance analysis).
The last transaction was made on
Oct 23, 2025
by
Craig Adam R
, who
bought
250k USD
worth of 
XFOR shares.
During the last 3 months X4 Pharmaceuticals Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 12% over this period (open performance analysis).
The last transaction was made on
Oct 23, 2025
by
Craig Adam R
, who
bought
250k USD
worth of XFOR shares.
X4 Pharmaceuticals Inc
Glance View
X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company is headquartered in Boston, Massachusetts and currently employs 83 full-time employees. The company went IPO on 2017-11-16. The firm is focused on the research, development and commercialization of therapeutics for the treatment of rare diseases with an initial focus on the treatment of people with immune system dysfunction. Its lead product candidate, mavorixafor, is a small molecule inhibitor of the chemokine receptor CXCR4 and is being developed as a once-daily oral therapy. Its mavorixafor demonstrated ability to antagonize CXCR4 and improve the healthy maturation and trafficking of white blood cells (WBCs), which provides therapeutic benefit across a variety of diseases, including primary immunodeficiencies (PIDs) and certain types of cancer. Its mavorixafor is in a global Phase III clinical trial for the treatment of warts, hypogammaglobulinemia, infections and myelokathexis (WHIM) syndrome, a rare, inherited PID caused by genetic mutations in the CXCR4 receptor gene. Its product candidates include X4P-001, X4P-002 and X4P-003.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
